Thyroidectomy: Microscopic Versus Conventional
Comparison of Outcomes of Microscopic Versus Conventional Thyroidectomy
1 other identifier
interventional
74
1 country
1
Brief Summary
Despite promising findings from international studies, the use of microscopic thyroidectomy remains limited in local surgical practice, where conventional thyroidectomy is traditionally followed. There is a scarcity of local data evaluating the benefits of MT, and inconsistencies in reported outcomes highlight the need for further research. The lack of standardized protocols and limited surgeon experience with microscopic techniques contribute to hesitation in its adoption. This study aims to address the research gap by providing comparative data on operative time, intraoperative blood loss, and postoperative complications in microscopic versus conventional thyroidectomy in our setting. The findings will aid in determining whether MT should be incorporated into routine surgical practice to improve patient outcomes and reduce postoperative complications.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Dec 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 16, 2025
CompletedFirst Submitted
Initial submission to the registry
March 15, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 15, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
March 15, 2026
CompletedFirst Posted
Study publicly available on registry
March 23, 2026
CompletedMarch 23, 2026
March 1, 2026
3 months
March 15, 2026
March 18, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Mean intraoperative blood loss
It will be defined as the mean total volume of blood lost during the surgical procedure, measured in milliliters (mL). Blood loss will be estimated using the difference between preoperative and postoperative suction canister volumes, accounting for irrigation fluids, and by weighing surgical sponges and gauze (1 g of blood = 1 mL).
0 days
Percentage of Transient Recurrent Laryngeal Nerve (RLN) Palsy
postoperative unilateral or bilateral impairment of vocal cord mobility due to RLN dysfunction, confirmed by indirect laryngoscopy or videolaryngostroboscopy performed by an otolaryngologist. Diagnosis will be based on reduced or absent vocal cord movement compared to preoperative assessment. Patients exhibiting hoarseness, breathiness, or dysphonia with confirmed vocal cord dysfunction on laryngoscopic evaluation within one month postoperatively will be labeled as transient RLN palsy. Any patient showing full recovery of vocal cord mobility on follow-up laryngoscopy at one month will be classified as transient.
one month
Percentage of Permanent Recurrent Laryngeal Nerve (RLN) Palsy
persistent postoperative unilateral or bilateral vocal cord paralysis confirmed by indirect laryngoscopy or videolaryngostroboscopy at one month postoperatively by an otolaryngologist. Diagnosis will require complete absence of vocal cord movement on objective examination at one month, without any signs of recovery. Patients with persistent hoarseness, dysphonia, or aspiration symptoms accompanied by vocal cord immobility at one month will be definitively classified as having permanent RLN palsy.
one month
percentage of Transient Hypocalcemia
It will be labeled as transient hypocalcemia if the patient experiences symptoms such as perioral numbness, carpopedal spasms, or tetany within one month of surgery, with laboratory confirmation of serum calcium \< 8.0 mg/dL. Diagnosis will be based on serial calcium measurements, and resolution within one month without continued supplementation will confirm its transient nature.
one month
Study Arms (2)
Microscopic Thyroidectomy
EXPERIMENTALConventional Thyroidectomy
PLACEBO COMPARATORInterventions
The procedure was done under general anesthesia but with an endotracheal intubation. Transverse cervical incision (45 cm) was done along a natural skin line. Magnification (Zeiss Sensera, 3-5x magnification) was employed in order to make the recurrent laryngeal nerve (RLN), external branch of the superior laryngeal nerve (EBSLN), and parathyroid glands easier to dissect. The ligatures were done at the superior pole of the thyroid gland and not at EBSLN. The RN was determined on the entry site to the larynx and kept in perfect condition. The parathyroid glands were distinguished, frozen or remedied in the event of the devascularization. The thyroid gland had been removed according to the intended operation (lobectomy, sub-total, or the total thyroidectomy). The wound was closed in layers and hemodynamics was restored
A similar method was employed except that no microscopic magnification was employed. The standard visual techniques were used to identify RN and EBSLN and the process was accomplished according to the traditional approach. The traditional methods were used to identify and preserve parathyroid glands without any further magnification. The recovery room paid close attention to patients following surgery in case of any immediate complications such as bleeding or airway obstruction. Serum calcium levels were tested 24 hours after operation to determine whether they were hypocalcaemic and indirect laryngoscopy carried out prior to discharge to determine the functioning of the vocal cords
Eligibility Criteria
You may qualify if:
- Both Male or female patients.
- Patients aged 18 to 65 years undergoing thyroidectomy for benign or malignant thyroid disease.
- Patients with multinodular goiter, Grave's disease, thyroid carcinoma indicated for surgery based on their workup.
- Candidates scheduled for unilateral lobectomy, subtotal thyroidectomy, or total thyroidectomy.
- Patients with preoperative normal vocal cord mobility confirmed by laryngoscopy.
- Hemodynamically stable patients without significant comorbidities affecting surgery or anesthesia based on ASA classification (Class I-III).
- Patients who provide informed consent to participate in the study.
You may not qualify if:
- Prior history of prior thyroid surgery.
- Patients with evidence of lateral lymph node metastasis or local invasion on preoperative imaging (ultrasonography or computed tomography).
- Patients with pre-existing hypocalcemia or parathyroid disorders.
- Patients with severe medical comorbidities, including uncontrolled diabetes (HbA1c \> 8%), chronic kidney disease (eGFR \< 30 mL/min/1.73m²), liver cirrhosis (Child-Pugh class B or C), or coagulopathy (INR \> 1.5 or platelet count \< 50,000/μL), will be excluded from the study.
- Pregnant or lactating women.
- Patients with invasive thyroid carcinoma, anaplastic thyroid carcinoma, or thyroid lymphoma requiring extensive radical surgery.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Shaikh Zayed Hospital, Lahore
Lahore, Punjab Province, 60000, Pakistan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
mudassar saeed pansota
Assistant Professor of Urology, Shahida Islam Teaching Hospital, Lodhran, Pakistan
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
March 15, 2026
First Posted
March 23, 2026
Study Start
December 16, 2025
Primary Completion
March 15, 2026
Study Completion
March 15, 2026
Last Updated
March 23, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share